US$ 21.08
cigna glp 1 program drops coverage of GLP-1 obesity drugs for its own employees Cigna is making GLP-1 coverage
Description
*These authors contributed equally to this work

This is the first one
Your healthcare provider determines the appropriate duration based on whether you have diabetes, your cardiovascular risk profile, and how you respond to treatment

However, weight reduction remains a significant challenge owing to multiple factors such as glucose-lowering therapies, insufficient lifestyle modifications, and socioeconomic status

Because obesity treatment is multimodal, it is essential to adhere to a healthy diet and exercise regularly to get the desired results
For some people, that is helpful
